Presentation is loading. Please wait.

Presentation is loading. Please wait.

811: False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute? 

Published byMathilda Bauwens Modified over 6 years ago

Similar presentations

Presentation on theme: "811: False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute? "— Presentation transcript:

1 811: False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute?  Gert-Jan van Baaren, Merel Bruijn, Jolande Vis, Femke Wilms, Martijn Oudijk, Anneke Kwee, Martina Porath, Guid Oei, Hubertina Scheepers, Marc Spaanderman, Kitty Bloemenkamp, Monique Haak, Antoinette Bolte, Caroline Bax, Jérôme Cornette, Johannes Duvekot, Maureen Franssen, Krystyna Sollie, Frank Vandenbussche, Mallory Woisky, William Grobman, Joris van der Post, Patrick Bossuyt, Brent Opmeer, Ben Mol  American Journal of Obstetrics & Gynecology  Volume 210, Issue 1, (January 2014) DOI: /j.ajog Copyright © Terms and Conditions

2 American Journal of Obstetrics & Gynecology 2014 210, DOI: (10. 1016/j
American Journal of Obstetrics & Gynecology  , DOI: ( /j.ajog ) Copyright © Terms and Conditions

Download ppt "811: False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute? "

Similar presentations

Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative Lauren E. Corona, BS, Carolyn W. Swenson, MD, Kyle.

Use of other treatments before hysterectomy for benign conditions in a statewide hospital collaborative Lauren E. Corona, BS, Carolyn W. Swenson, MD, Kyle.
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group Dirk Timmerman, MD, PhD,

Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis group Dirk Timmerman, MD, PhD,
Prediction of Preterm Birth in Multiple Pregnancies: Development of a Multivariable Model Including Cervical Length Measurement at 16 to 21 Weeks’ Gestation.

Prediction of Preterm Birth in Multiple Pregnancies: Development of a Multivariable Model Including Cervical Length Measurement at 16 to 21 Weeks’ Gestation.
Use of metformin in polycystic ovary syndrome Ruchi Mathur, MD, Carolyn J. Alexander, MD, Jacqueline Yano, MA, Bradley Trivax, MD, Ricardo Azziz, MD, MPH,

Use of metformin in polycystic ovary syndrome Ruchi Mathur, MD, Carolyn J. Alexander, MD, Jacqueline Yano, MA, Bradley Trivax, MD, Ricardo Azziz, MD, MPH,
First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix.

First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix.
Human trophoblasts confer resistance to viruses implicated in perinatal infection Avraham Bayer, BSc, Elizabeth Delorme-Axford, PhD, Christie Sleigher,

Human trophoblasts confer resistance to viruses implicated in perinatal infection Avraham Bayer, BSc, Elizabeth Delorme-Axford, PhD, Christie Sleigher,
Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism ‐ Based Prediction of Volume of Distribution Patrick Poulin, Frank ‐ Peter Theil.

Prediction of Pharmacokinetics Prior to In Vivo Studies. 1. Mechanism ‐ Based Prediction of Volume of Distribution Patrick Poulin, Frank ‐ Peter Theil.
Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm  Griselda Gutierrez, MD, FACOG, Joy.

Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm  Griselda Gutierrez, MD, FACOG, Joy.
Volume 387, Issue 10028, Pages (April 2016)

Volume 387, Issue 10028, Pages (April 2016)
319: Do 28 week ultrasound measurements of the fetal limb soft tissue predict adiposity at birth?  Gaea Moore, Amanda Allshouse, Barbra Fisher, Bronwen.

319: Do 28 week ultrasound measurements of the fetal limb soft tissue predict adiposity at birth?  Gaea Moore, Amanda Allshouse, Barbra Fisher, Bronwen.
Volume 382, Issue 9901, Pages (October 2013)

Volume 382, Issue 9901, Pages (October 2013)
Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity  Femke.

Relationship between the time interval from antenatal corticosteroid administration until preterm birth and the occurrence of respiratory morbidity  Femke.
25: Effect of sildenafil citrate on fetal central hemodynamics and placental volume blood flow during hypoxemia in a chronic sheep model  Leena Alanne,

25: Effect of sildenafil citrate on fetal central hemodynamics and placental volume blood flow during hypoxemia in a chronic sheep model  Leena Alanne,
Time to pregnancy after a previous miscarriage in subfertile couples

Time to pregnancy after a previous miscarriage in subfertile couples
American Journal of Obstetrics & Gynecology

American Journal of Obstetrics & Gynecology
5: Foley or Misoprostol for the Management of Induction (The ‘FOR MOMI’ trial): A four- arm randomized clinical trial  Lisa Danielle Levine, Mary D. Sammel,

5: Foley or Misoprostol for the Management of Induction (The ‘FOR MOMI’ trial): A four- arm randomized clinical trial  Lisa Danielle Levine, Mary D. Sammel,
On Electronic Fetal Heart Rate Monitoring

On Electronic Fetal Heart Rate Monitoring
54: Crew resource management (CRM) improves perinatal outcomes

54: Crew resource management (CRM) improves perinatal outcomes
Daphne N. Voormolen, J. H. DeVries, M. Kok, D. J. Bekedam, C. B

Daphne N. Voormolen, J. H. DeVries, M. Kok, D. J. Bekedam, C. B
425: Parity in relation to antithyroid peroxidase antibodies

425: Parity in relation to antithyroid peroxidase antibodies

Similar presentations

Ads by Google